Funding
Studies such as EMPA-KIDNEY take a very large amount of collaborative effort from many hundreds of research staff around the world and can be costly to run. The study is sponsored by Boehringer Ingelheim which is providing the study pills. Boehringer Ingelheim has also provided a grant to the University of Oxford. Those running the study at the University of Oxford also receive support from the UK Medical Research Council and British Heart Foundation to run trials.